JPH01136662A - Preparation of antibacterial urethral catheter - Google Patents

Preparation of antibacterial urethral catheter

Info

Publication number
JPH01136662A
JPH01136662A JP62296754A JP29675487A JPH01136662A JP H01136662 A JPH01136662 A JP H01136662A JP 62296754 A JP62296754 A JP 62296754A JP 29675487 A JP29675487 A JP 29675487A JP H01136662 A JPH01136662 A JP H01136662A
Authority
JP
Japan
Prior art keywords
catheter
latex
silver
protein silver
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62296754A
Other languages
Japanese (ja)
Other versions
JPH0634817B2 (en
Inventor
Yoshihiro Umemura
梅村 吉弘
Yasuhiko Ozaki
安彦 尾崎
Akihito Kawade
明史 川出
Isao Sawatani
澤谷 功
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAWATANI RUBBER KOGYO KK
Unitika Ltd
Original Assignee
SAWATANI RUBBER KOGYO KK
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAWATANI RUBBER KOGYO KK, Unitika Ltd filed Critical SAWATANI RUBBER KOGYO KK
Priority to JP62296754A priority Critical patent/JPH0634817B2/en
Publication of JPH01136662A publication Critical patent/JPH01136662A/en
Publication of JPH0634817B2 publication Critical patent/JPH0634817B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:To provide a urethral catheter having continued antibacterial activity itself by obtaining latex composition with high stability by combining highly water soluble protein silver to natural or synthetic gum latex. CONSTITUTION:A urethral catheter made of natural gum is usually prepared from natural gum latex by soaking moulding method. Therefore, by preparing specially natural gum latex compositions combined with protein silver as a coating solution, catheters can be manufactured by the same method as used conventionally. Protein silver may be applied evenly to whole layer of a catheter. However, taking into consideration manufacturing cost, it is preferable to apply it only to the inner and outer surfaces. To avoid unnecessary irritation to the urethral mucosa, it is preferable to apply protein silver only in the more distal part than the site of a balloon which is retained in the urinary bladder.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、導尿カテーテルの製造方法に関するものであ
り、さらに詳しくは、抗菌性能を有する導尿カテーテル
の製造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a method for manufacturing a urinary catheter, and more particularly, to a method for manufacturing a urinary catheter having antibacterial properties.

(従来の技術) 導尿カテーテルは現代の医療技術においては欠かせない
手段となっており、解剖学的な排尿障害又は生理学的な
排尿障害に対する一時的な尿路の確保、尿道や前立腺そ
の他周囲の組織に対する外科手術後の治癒を容易にする
ため、また、昏睡患者や尿失禁患者の尿路確保のために
広く用いられている。しかし、不幸にしてその管理を誤
ると。
(Prior technology) Urinary catheters have become an indispensable tool in modern medical technology, and are used to temporarily secure the urinary tract for anatomical or physiological urinary disorders, and to treat urinary problems such as the urethra, prostate, and other surrounding areas. It is widely used to facilitate healing after surgical procedures on tissues of the body, and to secure the urinary tract in comatose and incontinent patients. However, if it is mismanaged unfortunately.

あるいは細心の注意をもってしても、以下のように本来
看護すべきはずの患者に害を及ぼすことが知られている
。すなわち、カテーテルの管腔内外を通して外界からの
細菌による尿路感染症を高頻度に招来することが知られ
ている。
Furthermore, even with the utmost care, it is known that harm can be caused to the patients who should be cared for, as shown below. That is, it is known that bacteria from the outside world frequently cause urinary tract infections through the inside and outside of the lumen of the catheter.

ところでカテーテル留置に伴う尿路感染を防止するため
に、従来はともすれば抗生剤の投与による化学療法に頼
り勝ちであったが、安易な化学療法は一旦感染菌が消滅
しても新たに耐性菌による感染を招くこともあり、かえ
って危険であることが指摘されている。したがって、化
学療法は今日では、腎孟腎炎による発熱時など必要最小
限の場合にのみとどめるべきであるとされている。
By the way, in order to prevent urinary tract infections associated with catheter placement, conventional chemotherapy using antibiotics has been relied upon, but easy chemotherapy can cause new resistant bacteria to develop even after the infecting bacteria have been eradicated. It has been pointed out that it is actually dangerous, as it can lead to bacterial infection. Therefore, it is now believed that chemotherapy should be used only when necessary, such as when fever is caused by pyelonephritis.

これに対し近年、カテーテル留置局所での感染を防止す
るために閉鎖式導尿システムが普及しつつあり、従来の
開放式と比べると著しい尿路感染防止効果が認められて
いる。しかし、閉鎖式導尿システムは、開放式導尿シス
テムと比較したとき ゛蓄尿バックからの管内経路によ
る逆行感染を防ぐ上では有効であるが、カテーテルと導
尿チューブの連結部の着脱による汚染及びカテーテル外
周と尿道粘膜との間からの管外感染に対しては無効であ
ることが知られている。したがって2例えば。
On the other hand, in recent years, closed urinary catheter systems have become popular in order to prevent infection at the site where the catheter is placed, and have been found to be more effective in preventing urinary tract infections than conventional open systems. However, when compared to open urinary drainage systems, closed urinary drainage systems are effective in preventing retrograde infection through the intraductal route from the urine collection bag, but they are less susceptible to contamination due to attachment and detachment of the connection between the catheter and the urinary tube. It is known to be ineffective against extraluminal infections between the outer circumference of the catheter and the urethral mucosa. Therefore 2 e.g.

抗生剤非投与患者群については5日間の体内留置におい
てもなお40%前後の累積感染が認められているのが現
状である。
Currently, cumulative infections of around 40% are still observed in the group of patients not receiving antibiotics even after 5 days of indwelling in the body.

このため、最近では導尿カテーテル留置局所での細菌感
染を根本的に防止するために、導尿カテーテル自体が、
抗菌性能を有するタイプのものが強く望まれている。
For this reason, recently, in order to fundamentally prevent bacterial infection at the site where the urinary catheter is placed, the urinary catheter itself has been
A type with antibacterial properties is strongly desired.

従来より、医療用具に持続的な抗菌活性を賦与する最も
有効な方法としては、その使用過程において一定濃度以
上の抗菌剤を基材中又は基材表面に保持させるよう抗菌
剤を分散させた。いわゆるマトリックスデバイスがシス
テムとして考えられている。
Conventionally, the most effective method for imparting sustained antibacterial activity to medical devices has been to disperse antibacterial agents so that a certain concentration or higher of the antibacterial agent is retained in or on the surface of the substrate during the course of its use. A so-called matrix device is considered as a system.

他方、金、銀、銅、亜鉛などの重金属ならびにこれらの
金属化合物は、各々金属イオンの状態において極めて微
量の濃度で細菌、真菌などの微生物に対して強い殺菌効
果を持つことが知られており、オリゴダイナミーと呼ば
れている。   ′以上述べたような観点から、上記金
属、とくに銀化合物の持つオリゴダイナミーを利用し、
基材上に金属体を被着させたもの、あるいは基材中に金
属を分散、配合した用具が提案されている。
On the other hand, heavy metals such as gold, silver, copper, and zinc, as well as their metal compounds, are known to have strong bactericidal effects against microorganisms such as bacteria and fungi at extremely small concentrations in the form of metal ions. , is called oligodynamism. 'From the above-mentioned viewpoint, by utilizing the oligodynamics of the above metals, especially silver compounds,
Tools have been proposed in which a metal body is adhered to a base material, or a tool in which a metal is dispersed or blended in the base material.

例えば、特開昭52−62996号公報には。For example, in Japanese Patent Application Laid-Open No. 52-62996.

可撓性管体の表面にオリゴダイナミーを有する金属体、
あるいは金属体からなるリング、ネットなどを被着させ
たカテーテルが提案されている。しかし、成型されたカ
テーテルの表面に金属体を被着する操作は非常に面倒で
複雑であり、実製造現場における生産効率は低い。
a metal body having oligodynamics on the surface of a flexible tube;
Alternatively, a catheter covered with a ring, net, etc. made of a metal body has been proposed. However, the operation of attaching a metal body to the surface of a molded catheter is extremely troublesome and complicated, and the production efficiency in actual manufacturing sites is low.

また、特開昭59−218517号公報には。Also, in JP-A-59-218517.

抗微生物性金属化合物を30μ以内の粒子に粉砕後、カ
テーテルを形成し得る懸濁剤中に分散し。
The antimicrobial metal compound is ground into particles within 30 microns and then dispersed in a suspension capable of forming a catheter.

硬化させて抗微生物活性を有するカテーテルを形成する
方法が記載されている。しかしながら、金属化合物を3
0μ以内の粒子にする粉砕する工程及び粉砕した金属化
合物の粒子の再凝集を防ぎ。
A method of curing to form a catheter with antimicrobial activity is described. However, 3 metal compounds
Prevents the pulverization process into particles with a size of 0μ or less and the re-agglomeration of the pulverized metal compound particles.

安定した粒子状態を保つために、いわゆる界面活性剤な
どの添加が必要であり、生産コストの上昇となる。
In order to maintain a stable particle state, it is necessary to add a so-called surfactant, which increases production costs.

一般に銀化合物及び銀塩の水に対する溶解度が低いため
に、溶液状態でラテックスに配合したときは基材中の銀
濃度が非常に低(なる。また、基材中の銀濃度を高くす
るために9例えば、水溶解度の高い硝酸銀などを水溶液
にしてラテックスに添加した場合には、その理由は明ら
かではないが。
In general, silver compounds and silver salts have low solubility in water, so when they are mixed into latex in a solution state, the silver concentration in the base material is very low. 9 For example, when an aqueous solution of silver nitrate, etc., which has high water solubility, is added to latex, the reason for this is not clear.

ラテックスが水溶液中に安定に浮遊している系を破壊せ
しめ、凝集が生じ、安定したラテックス組成物を得るこ
とができない。
This destroys the system in which latex is stably suspended in an aqueous solution and causes aggregation, making it impossible to obtain a stable latex composition.

したがって、オリゴダイナミーを利用して、それ自体が
抗菌性能を有するタイプの導尿カテーテルを製造するに
は、上記したようにカテーテルを成型後、その表面に金
属体を被着させる工程又は金属化合物を微小な粒子に粉
砕し、懸濁液中に分散する工程が必要であり、これらは
生産効率が低く、また製造におけるコスト上昇となり2
問題点となっている。
Therefore, in order to manufacture a type of urinary catheter that itself has antibacterial properties by utilizing oligodynamics, the process of molding the catheter as described above and then applying a metal body to its surface or using a metal compound. It requires a process of pulverizing it into fine particles and dispersing it into a suspension, which has low production efficiency and increases manufacturing costs.
This has become a problem.

(発明が解決しようとする問題点) 本発明の目的は、導尿カテーテル自体が持続的な抗菌活
性を有する抗菌性導尿カテーテルの製造方法を提供する
ことにある。
(Problems to be Solved by the Invention) An object of the present invention is to provide a method for manufacturing an antibacterial urinary catheter in which the urinary catheter itself has continuous antibacterial activity.

また2本発明の他の目的は、簡単な操作で、工業的に生
産性良く抗菌性導尿カテーテルを製造する方法を提供す
ることにある。
Another object of the present invention is to provide a method for manufacturing an antibacterial urinary catheter with high industrial productivity using simple operations.

また2本発明の他の目的は、銀化合物を含有するラテッ
クス組成物からなるコーティング液を用いて抗菌性導尿
カテーテルを安定に製造する方法を提供することにある
Another object of the present invention is to provide a method for stably manufacturing an antibacterial urinary catheter using a coating liquid made of a latex composition containing a silver compound.

(問題点を解決するための手段) 本発明者らは、上記のごとき目的を達成すべく鋭意研究
を重ねた結果、天然ゴムラテックス又は合成ゴムラテッ
クスに水溶解度の高いプロティン銀を配合することによ
り、安定性に優れたラテツクス組成物が得られ、コーテ
ィング液としてこの組成物を用いることによって所期の
目的を達成しうろことを見い出し2本発明に到達した。
(Means for Solving the Problems) As a result of extensive research to achieve the above objectives, the present inventors have found that by blending protein silver with high water solubility into natural rubber latex or synthetic rubber latex. The inventors have now found that a latex composition with excellent stability has been obtained, and that the intended purpose can be achieved by using this composition as a coating liquid, thus achieving the present invention.

すなわち1本発明は、天然ゴムラテックス又は合成ゴム
ラテックスからなるコーティング液を用い、コーティン
グ法にて導尿カテーテルを製造するに際し、コーティン
グ液として天然ゴムラテックス又は合成ゴムラテックス
にプロティン銀を配合したラテックス組成物を用いるこ
とを特徴とする抗菌性導尿カテーテルの製造方法を要旨
とするものである。
That is, 1. the present invention provides a latex composition in which protein silver is blended with natural rubber latex or synthetic rubber latex as the coating liquid when manufacturing a urinary catheter by a coating method using a coating liquid made of natural rubber latex or synthetic rubber latex. The gist of the present invention is a method for manufacturing an antibacterial urinary catheter characterized by using an antibacterial urinary catheter.

本発明に用いられる天然ゴムラテックスとは。What is the natural rubber latex used in the present invention?

ゴム植物の樹皮に切付を行った時に流れ出る種々の有機
物及び無機物を含有した水溶液を分散媒体とし、ゴム分
を分散質とし、必要に応じてpH調整剤、加硫剤、加硫
促進剤、軟化剤、充填剤、老化防止剤1着色剤などを配
合したラテックスである。
An aqueous solution containing various organic and inorganic substances that flows out when the bark of a rubber plant is cut is used as a dispersion medium, and the rubber component is used as a dispersoid. It is a latex containing softeners, fillers, anti-aging agents, colorants, etc.

また9本発明に用いられる合成ゴムラテックスとしては
1例えば、エチレン、スチレン、酢酸ビニル、塩化ビニ
ル、塩化ビニリデン、アクリロニトリル、 (メタ)ア
クリル酸エステル、ビニルピリジン、メチルビニルエー
テルなどのビニル系モノマーの単一重合体又はその共重
合体、ブタジェン、イソプレン、I+3−ペンタジェン
、1,5−へキサジエン、1)6−ヘプタジエン、クロ
ロプレンなどのジエン系モノマーの単一重合体あるいは
その共重合体、上記ビニル系モノマーとジエン系モノマ
ーの共重合体、その他官能基としてエポキシド基、アミ
ノ基、カルボキシル基、酸無水物基。
9 Examples of the synthetic rubber latex used in the present invention include 1 monomer polymers of vinyl monomers such as ethylene, styrene, vinyl acetate, vinyl chloride, vinylidene chloride, acrylonitrile, (meth)acrylic acid ester, vinyl pyridine, and methyl vinyl ether. Polymers or copolymers thereof, homopolymers of diene monomers such as butadiene, isoprene, I+3-pentadiene, 1,5-hexadiene, 1) 6-heptadiene, chloroprene, or copolymers thereof, the above vinyl monomers and dienes Copolymers of monomers, and other functional groups such as epoxide groups, amino groups, carboxyl groups, and acid anhydride groups.

水酸基、アミド基、N−メチロールアミド基、イソシア
ネート基などを有するビニル系モノマーと上記各種モノ
マーとの共重合体などを主成分とし。
The main component is a copolymer of a vinyl monomer having a hydroxyl group, an amide group, an N-methylolamide group, an isocyanate group, etc., and the various monomers mentioned above.

必要に応じて界面活性剤、架橋剤、充填剤、軟化剤など
を配合したものがあげられる。
Examples include those containing surfactants, crosslinking agents, fillers, softeners, etc. as necessary.

本発明においては、抗菌剤としてプロティン銀を用いる
。プロティン銀は、タンパク質と銀との化合物であり2
日本薬局方に収載されている銀として7.5〜8.5重
量%含まれるものが好ましく用いられる。
In the present invention, protein silver is used as an antibacterial agent. Protein silver is a compound of protein and silver.
Silver containing 7.5 to 8.5% by weight of silver listed in the Japanese Pharmacopoeia is preferably used.

プロティン銀の好ましい配合量は、その目的とするとこ
ろにより異なるが、−船釣には、ラテックスの固形分に
対し、銀として0.1〜10重量%。
The preferred amount of protein silver varies depending on the purpose, but for boat fishing, it is 0.1 to 10% by weight of silver based on the solid content of latex.

とくに0.5〜5重量%であることが好ましい。In particular, it is preferably 0.5 to 5% by weight.

本発明においてコーティング液を調製する方法は、各成
分が均一に混合される方法であれば特に限定されず、公
知の種々の方法を利用することができる。例えば、プロ
ティン銀の水溶液を直接ラテックス中に添加するなどの
方法が好ましく採用される。
The method for preparing the coating liquid in the present invention is not particularly limited as long as each component is mixed uniformly, and various known methods can be used. For example, a method of directly adding an aqueous solution of protein silver into the latex is preferably employed.

本発明の方法により導尿カテーテルを製造するには、従
来公知のいかなる方法によってもよい。
Any conventionally known method may be used to manufacture a urinary catheter according to the method of the present invention.

例えば、天然ゴムを素材とする導尿カテーテルは。For example, urinary catheters are made from natural rubber.

通常天然ゴムラテックスからコーティング法の一つであ
る浸漬成形法によって作られるため、コーティング液と
して上記プロティン銀を配合した天然ゴムラテックス組
成物を特別に調製することにより、従来と全く同じ製造
法で製造することができる。また、コーティング液とし
てその他の合成ゴムラテックス組成物を用いるときにも
同様にして同種の基材又は異種の基材からなる半製品を
コ一ティング液に浸漬するか又は半製品にコーティング
液をスプレーする。いわゆるコーティング法によって製
造することができる。
Since it is usually made from natural rubber latex by dip molding, which is one of the coating methods, by specially preparing a natural rubber latex composition containing the protein silver mentioned above as a coating liquid, it can be manufactured using the same manufacturing method as before. can do. In addition, when using other synthetic rubber latex compositions as a coating liquid, similarly, semi-finished products made of the same type of base material or different types of base materials are immersed in the coating liquid, or the coating liquid is sprayed onto the semi-finished product. do. It can be manufactured by a so-called coating method.

プロティン銀は、カテーテルの全層に均等に配合されて
いてもよいが、製造コストを勘案すると。
Protein silver may be evenly blended into all layers of the catheter, but considering manufacturing costs.

カテーテルの内表面及び外表面にのみ限定することが好
ましい。また、カテーテルの外表面に関しては、尿道粘
膜への無用な刺激を避ける観点から。
Preferably, it is limited only to the inner and outer surfaces of the catheter. Also, regarding the outer surface of the catheter, from the perspective of avoiding unnecessary irritation to the urethral mucosa.

膀胱内に留置されるバルーンより先端部のみにプロティ
ン銀を配合することもできる。
Protein silver can also be added only to the tip of the balloon that is placed in the bladder.

(実施例) 以下、実施例をあげて本発明をさらに具体的に説明する
(Examples) Hereinafter, the present invention will be explained in more detail by giving examples.

なお2例中の「部」は「重量部」を意味する。Note that "parts" in the two examples mean "parts by weight."

実施例1 固型分濃度が約50重量%の天然ゴムラテックス100
部に、ジメチルジチオカルバミン酸亜鉛0.3部、硫黄
1.5部、亜鉛華3部及びステアリン酸1.2部を均一
に分散させて、天然ゴムを主成分とする配合ラテックス
(以下、A液という。)を調製した。一方、プロティン
銀6.4部を蒸溜水20部に溶解し、これを上記A液1
00部に攪拌上添加してコーティング液を調製した、コ
ーティング液は何ら凝集することなくプロティン銀が。
Example 1 Natural rubber latex 100 with a solid content concentration of about 50% by weight
0.3 parts of zinc dimethyldithiocarbamate, 1.5 parts of sulfur, 3 parts of zinc white, and 1.2 parts of stearic acid are uniformly dispersed in 1 part of the compound latex (hereinafter referred to as part A) containing natural rubber as the main component. ) was prepared. On the other hand, 6.4 parts of protein silver was dissolved in 20 parts of distilled water, and this was added to the above solution A1.
A coating liquid was prepared by adding protein silver to 0.00 parts with stirring, and the coating liquid contained protein silver without any agglomeration.

配合ラテックス中に均一に分散したコーティング液(銀
1重量%)を得ることができた。
A coating solution (silver 1% by weight) uniformly dispersed in the compounded latex could be obtained.

このコーティング液を用いて2通常の浸漬成形法により
、S尿カテーテル用浸漬型を、上記コーティング液浸漬
液中に浸漬したのち引き上げ、乾燥(80℃、5分)す
るという操作を5〜7回繰り返し、最後に70℃で10
時間熱処理を行って導尿カテーテルを得た。
Using this coating liquid, the immersion mold for S urinary catheter is immersed in the above coating liquid immersion liquid and then pulled out and dried (80°C, 5 minutes) 5 to 7 times using the normal immersion molding method. Repeat, and finally at 70℃ for 10
A urinary catheter was obtained by performing heat treatment for a period of time.

得られた導尿カテーテルを切断し、その切片を無菌環境
下で70%エタノール水溶液で洗浄し。
The obtained urinary catheter was cut, and the section was washed with a 70% ethanol aqueous solution in a sterile environment.

エタノールを乾燥、留去した後、サンプル瓶の底に内表
面が上を向くように置いた。ついで、切片の内表面上に
、大腸菌を一晩37℃でトリプチケースソイブロスで培
養した菌液を200μβ置き。
After drying and distilling off the ethanol, it was placed on the bottom of a sample bottle with the inner surface facing upward. Next, 200 μβ of E. coli cultured in trypticase soy broth at 37° C. overnight was placed on the inner surface of the section.

密栓後、37℃で18時間培養した。その後、サンプル
瓶に0.1%の界面活性剤(Tween 80.山桂産
業)を含む生理食塩水を加えて菌液を回収し。
After sealing, the cells were cultured at 37°C for 18 hours. Thereafter, physiological saline containing 0.1% surfactant (Tween 80, Sankei Sangyo) was added to the sample bottle to collect the bacterial solution.

コロニーカウント法により生存菌数を測定したところ9
回収された菌数は5.OXIO3であった。
When the number of viable bacteria was measured using colony counting method, it was 9.
The number of bacteria recovered was 5. It was OXIO3.

また、実施例1の導尿カテーテルを室温の水に1週間浸
漬したのち、乾燥し、上記と同じ方法で生存菌数を測定
したところ1回収された菌数は4.2 XIO’であっ
た。
In addition, the urinary catheter of Example 1 was immersed in water at room temperature for one week, dried, and the number of viable bacteria was measured in the same manner as above, and the number of bacteria recovered was 4.2 XIO'. .

比較例1 コーティング液としてA液のみからなるコーティング液
を用いた以外は実施例1と同様にして導尿カテーテルを
得た。得られた導尿カテーテルについて実施例1と同様
の方法で抗菌活性テストを行ったところ2回収された菌
数は8.0 XlO7であった。
Comparative Example 1 A urinary catheter was obtained in the same manner as in Example 1 except that a coating liquid consisting of only liquid A was used as the coating liquid. When the obtained urinary catheter was subjected to an antibacterial activity test in the same manner as in Example 1, the number of bacteria recovered was 8.0 XlO7.

実施例2 コーティング液としてプロティン銀3.4部を蒸溜水8
部に溶解し、これを上記A液100部に攪押下添加して
調製したコーティング液(銀0.5重量%)を用いた以
外は実施例1と同様にして導尿カテーテルを得、得られ
た導尿カテーテルについて実施例1と同様の方法で抗菌
活性テストを行った。その結果1回収された菌数は2.
5 Xl06であった。
Example 2 3.4 parts of protein silver was added to 8 parts of distilled water as a coating liquid.
A urinary catheter was obtained in the same manner as in Example 1, except that a coating liquid (0.5% by weight of silver) was prepared by dissolving 100 parts of liquid A into 100 parts of liquid A and adding it under stirring to 100 parts of liquid A. An antibacterial activity test was conducted on the urinary catheter in the same manner as in Example 1. As a result, the number of bacteria recovered was 2.
5Xl06.

(発明の効果) 本発明によれば、特別な工夫や高度な技術を要すること
なく、天然ゴム又は合成ゴムラテックスにプロティン銀
を配合したラテックス組成物を通常の生産ラインに組み
込むだけで、持続的な抗菌活性を有する導尿カテーテル
を安定して製造できるので、その工業的意義は極めて大
きいものがある。
(Effects of the Invention) According to the present invention, a latex composition in which protein silver is blended with natural rubber or synthetic rubber latex can be incorporated into a normal production line without requiring any special devices or advanced technology. Since a urinary catheter having strong antibacterial activity can be stably manufactured, its industrial significance is extremely large.

特許出願人  ユニ子力株式会社 特許出願人  澤谷ゴム工業株式会社Patent applicant: Unikorikiki Co., Ltd. Patent applicant: Sawaya Rubber Industries Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] (1)天然ゴムラテックス又は合成ゴムラテックスから
なるコーティング液を用い、コーティング法にて導尿カ
テーテルを製造するに際し、コーティング液として天然
ゴムラテックス又は合成ゴムラテックスにプロテイン銀
を配合したラテックス組成物を用いることを特徴とする
抗菌性導尿カテーテルの製造方法。
(1) When manufacturing a urinary catheter by the coating method using a coating liquid made of natural rubber latex or synthetic rubber latex, a latex composition in which protein silver is blended with natural rubber latex or synthetic rubber latex is used as the coating liquid. A method for manufacturing an antibacterial urinary catheter characterized by:
JP62296754A 1987-11-25 1987-11-25 Method for manufacturing antibacterial urinary catheter Expired - Lifetime JPH0634817B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62296754A JPH0634817B2 (en) 1987-11-25 1987-11-25 Method for manufacturing antibacterial urinary catheter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62296754A JPH0634817B2 (en) 1987-11-25 1987-11-25 Method for manufacturing antibacterial urinary catheter

Publications (2)

Publication Number Publication Date
JPH01136662A true JPH01136662A (en) 1989-05-29
JPH0634817B2 JPH0634817B2 (en) 1994-05-11

Family

ID=17837681

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62296754A Expired - Lifetime JPH0634817B2 (en) 1987-11-25 1987-11-25 Method for manufacturing antibacterial urinary catheter

Country Status (1)

Country Link
JP (1) JPH0634817B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925355B2 (en) 2012-11-12 2018-03-27 Hollister Incorporated Intermittent catheter assembly and kit
US10220185B2 (en) 2012-11-14 2019-03-05 Hollister Incorporated Disposable catheter with selectively degradable inner core
US10420859B2 (en) 2013-12-12 2019-09-24 Hollister Incorporated Flushable catheters
US10426918B2 (en) 2013-12-12 2019-10-01 Hollister Incorporated Flushable catheters
US10463833B2 (en) 2013-12-12 2019-11-05 Hollister Incorporated Flushable catheters
CN111363780A (en) * 2018-12-25 2020-07-03 河南驼人贝斯特医疗器械有限公司 Detection method for antibacterial performance of antibacterial catheter
US10821209B2 (en) 2013-11-08 2020-11-03 Hollister Incorporated Oleophilic lubricated catheters
US10874769B2 (en) 2013-12-12 2020-12-29 Hollister Incorporated Flushable disintegration catheter
US11185613B2 (en) 2015-06-17 2021-11-30 Hollister Incorporated Selectively water disintegrable materials and catheters made of such materials

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103768700B (en) * 2013-07-03 2015-11-18 苏州睿研纳米医学科技有限公司 Antibacterial catheter of albumen and preparation method thereof

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925355B2 (en) 2012-11-12 2018-03-27 Hollister Incorporated Intermittent catheter assembly and kit
US10220185B2 (en) 2012-11-14 2019-03-05 Hollister Incorporated Disposable catheter with selectively degradable inner core
US10821209B2 (en) 2013-11-08 2020-11-03 Hollister Incorporated Oleophilic lubricated catheters
US11833274B2 (en) 2013-11-08 2023-12-05 Hollister Incorporated Oleophilic lubricated catheters
US10420859B2 (en) 2013-12-12 2019-09-24 Hollister Incorporated Flushable catheters
US10426918B2 (en) 2013-12-12 2019-10-01 Hollister Incorporated Flushable catheters
US10463833B2 (en) 2013-12-12 2019-11-05 Hollister Incorporated Flushable catheters
US10874769B2 (en) 2013-12-12 2020-12-29 Hollister Incorporated Flushable disintegration catheter
US11318279B2 (en) 2013-12-12 2022-05-03 Hollister Incorporated Flushable catheters
US11185613B2 (en) 2015-06-17 2021-11-30 Hollister Incorporated Selectively water disintegrable materials and catheters made of such materials
CN111363780A (en) * 2018-12-25 2020-07-03 河南驼人贝斯特医疗器械有限公司 Detection method for antibacterial performance of antibacterial catheter

Also Published As

Publication number Publication date
JPH0634817B2 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
US7381751B2 (en) Antimicrobial composition for medical articles
US4603152A (en) Antimicrobial compositions
US4677143A (en) Antimicrobial compositions
US10709819B2 (en) Method for coating catheters with a layer of antimicrobial agent
CN102272245A (en) Antimicrobial UV curable coating compositions
EP0141628A1 (en) Antimicrobial latex composition shaped article produced therefrom, and method of manufacturing a shaped article
JP2005511144A (en) Microbial-resistant medical device, microbial-resistant polymer coating and production method thereof
EP0124536A4 (en) Antimicrobial compositions.
US20220354985A1 (en) Anti-Microbial Medical Materials and Devices
JPH01136662A (en) Preparation of antibacterial urethral catheter
CN105596367A (en) Nano-silver antibacterial gel with chitosan-poloxamer as gel matrix and preparation method and application of nano-silver antibacterial gel
CN113773525B (en) Preparation method and application of molybdenum disulfide-loaded nano-silver antibacterial hydrogel
CN103142649B (en) Preparation method of amylose-coated I3<->-complexed silver-coated iron composite nanoparticles
CN104784103B (en) Based on oligomeric amino acid amphiphile, amphiphilic molecule injectable anti-bacterial hydrogel
CN109939267A (en) A kind of antimicrobial form catheter polymer composite and preparation method thereof
CN106146776A (en) Antibacterial polymer and the material of preparation thereof and purposes
JPH0580225B2 (en)
CN115737538A (en) Chitosan/dialdehyde sodium alginate/dopamine magnetic hydrogel and preparation method and application thereof
JP2636838B2 (en) Antimicrobial sustained release urinary catheter
CN107595819A (en) A kind of Nano diamond modified liquid adhesive bandage and preparation method thereof
CN111803705B (en) Hydroxyapatite composite material with antibacterial function and preparation method and application thereof
CN108815583B (en) Super-hydrophilic antibacterial ureter based on amino nano-silver molecular brush and preparation method thereof
EP3235926A1 (en) Sonochemical coating method
CN108938559B (en) DNA gel sterilization material, preparation method thereof and application of DNA gel sterilization material as sterilization material
JP2001029451A (en) Antibacterial urethral catheter and manufacture of the same

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080511

Year of fee payment: 14